Parkervision, Inc. v. Qualcomm Inc., Appeal Nos. 2022-1755, 2024-2221 (Fed. Cir. Sept. 6, 2024)
In this week’s Case of the Week, the Federal Circuit weighed in again on a 13-year-old patent dispute concerning Qualcomm’s...more
9/10/2024
/ Appeals ,
Daubert Standards ,
Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Intrinsic Evidence ,
Jury Verdicts ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Reversal
Wisconsin Alumni Research Foundation v. Apple Inc., Appeal Nos. 2022-1884, -1886 (Fed. Cir. Aug. 28, 2024)
In its only precedential patent decision last week, the Federal Circuit brought to a close a long-running dispute...more
Realtime Adaptive Streaming L.L.C. v. Sling TV, L.L.C., Appeal No. 2023-1035 (Fed. Cir. August 23, 2024)
In its only precedential patent decision this week, the Federal Circuit helped clarify which facts may be...more
8/27/2024
/ Appeals ,
Attorney's Fees ,
Exceptional Case ,
Inter Partes Review (IPR) Proceeding ,
Patent Invalidity ,
Patent Litigation ,
Patents ,
Precedential Opinion ,
Remand ,
Section 101 ,
Section 285
Allergan USA, Inc. v. MSN Laboratories Private Ltd., Appeal No. 2024-1061 (Fed. Cir. August 13, 2024)
In this week’s Case of the Week, the Federal Circuit clarifies rules relating to when an applicant’s patent can be...more
8/20/2024
/ Appeals ,
Article III ,
Constitutional Challenges ,
EU ,
Helsinn Healthcare SA v Teva Pharmaceuticals USA Inc ,
Inter Partes Review (IPR) Proceeding ,
International Trade Commission (ITC) ,
Inventions ,
Inventors ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Patents ,
SCOTUS
Mobile Acuity Ltd. v. Blippar Ltd., Appeal No. 2022-2216 (Fed. Cir. Aug. 6, 2024)
In its only precedential patent opinion last week, the Federal Circuit confirmed the invalidity of all claims of two asserted patents as...more
Sanho Corp. v. Kaijet Technology International Limited Inc., Appeal No. 2023-1336 (Fed. Cir. July 31, 2024)
In our Case of the Week, the Federal Circuit held that the private but non-confidential sale of thousands of...more
8/7/2024
/ Appeals ,
Claim Construction ,
Final Written Decisions ,
Inventions ,
Inventors ,
Obviousness ,
Patent Invalidity ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Prior Art ,
Public Disclosure
Zyxel Comms. Corp. v. UNM Rainforest Innovations, Appeal Nos. 2022-2220, -2250 (Fed. Cir. July 22, 2024)
Our Case of the Week provided new guidance on amendment proceedings under the Patent Trial and Appeal Board’s 2019...more
Backertop Licensing LLC v. Canary Connect, Inc., Appeal Nos. 2023-2367, -2368, 2024-1016, -1017 (Fed. Cir. July 16, 2024)
Our case of the week focuses on the inherent power of the district courts to investigate fraud and...more
7/23/2024
/ Appeals ,
Civil Contempt Orders ,
Dismissals ,
Fraud ,
Inter Partes Review (IPR) Proceeding ,
Investigations ,
Monetization ,
Mootness ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Professional Misconduct ,
Rule 45 ,
Sanctions ,
Section 101
Natera, Inc. v. NeoGenomics Laboratories, Inc., Appeal Nos. 2024-1324, -1409 (Fed. Cir. July 12, 2024)
In its only precedential patent opinion last week, the Federal Circuit affirmed a preliminary injunction that largely...more
Amarin Pharma, Inc. v. Hikma Pharms. USA Inc., Appeal No. 2023-1169 (Fed. Cir. June 25, 2024)
In the Court’s only precedential patent opinion last week, the Federal Circuit reversed the district court’s dismissal of...more
Beteiro, LLC v. Draftkings Inc., Appeal Nos. 2022-2275, -2277, -2278, -2279, -2281, 2283 (Fed. Cir. June 21, 2024)
In its only precedential patent opinion this week, the Federal Circuit affirmed the Rule 12(b)(6)...more
6/25/2024
/ Abstract Ideas ,
Alice/Mayo ,
Appeals ,
Dismissals ,
Eligibility Determination ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Patent Infringement ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patents ,
Precedential Opinion
EcoFactor, Inc. v. Google LLC, Appeal No. 2023-1101 (Fed. Cir. June 3, 2024)
In the Federal Circuit’s only precedential patent opinion this week, the court addressed issues of infringement and admissibility that arose...more
Copan Italia SPA v. Puritan Med. Prods. Co. LLC, Appeal No. 2022-1943 (Fed. Cir. May 14, 2024)
The Federal Circuit’s only precedential opinion concerning a patent case this week had nothing to do with patent law....more
5/21/2024
/ Appeals ,
Coronavirus/COVID-19 ,
Final Judgment ,
Inter Partes Review (IPR) Proceeding ,
Life Sciences ,
Motion to Dismiss ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Patents ,
Precedential Opinion
Zircon Corp. v. International Trade Commission, Appeal No. 2022-1649 (Fed. Cir. May 8, 2024)
In its only precedential patent opinion this week, the Federal Circuit made clear that in exclusion proceedings under 19 U.S.C....more
SnapRays v. Lighting Defense Group, Appeal No. 2023-1184 (Fed. Cir. May 2, 2024)
Our Case of the Week deals with an issue the Court has not addressed recently: the question of declaratory judgment jurisdiction....more
5/7/2024
/ Anticipation ,
Appeals ,
Claim Construction ,
Damages ,
Declaratory Judgments ,
Inter Partes Review (IPR) Proceeding ,
Mootness ,
Obviousness ,
Patent Infringement ,
Patent Litigation ,
Patent Ownership ,
Patent Trial and Appeal Board ,
Patents ,
Personal Jurisdiction ,
Printed Matter Doctrine ,
Remand ,
Vacated
Janssen Pharms., Inc. et al. v. Teva Pharm. USA, Inc. et al., Appeal Nos. 2022-1258, -1307 (Fed. Cir. April 1, 2024)
In this week’s Case of the Week, the Federal Circuit vacated-in-part a district court’s bench trial...more
4/9/2024
/ Abstract Ideas ,
Appeals ,
Claim Construction ,
Janssen Pharmaceuticals ,
Obviousness ,
Patent Infringement ,
Patent Invalidity ,
Patent Litigation ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Prior Art ,
Remand ,
Teva Pharmaceuticals
Harris Brumfield v. IBG LLC, Appeal No. 2022-1630 (Fed. Cir. Mar. 27, 2024)
In our case of the week, the Federal Circuit addressed three issues in a dispute that dates back to 2010, and has been to the Court on three...more
4/2/2024
/ Appeals ,
Damages ,
Deficiency Judgments ,
Discovery ,
Extraterritoriality Rules ,
Intellectual Property Protection ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Remand ,
Summary Judgment ,
Vacated
Pfizer Inc. v. Sanofi Pasteur Inc., Appeal Nos. 2019-1871, -1873, -1875, -1876, -2224 (Fed. Cir. Mar. 5, 2024)
This week’s Case of the Week mostly resolves an appeal filed five years ago, following decisions from the...more
3/12/2024
/ Alice/Mayo ,
Appeals ,
Claim Construction ,
Inter Partes Review (IPR) Proceeding ,
Obviousness ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patent-Eligible Subject Matter ,
Patents ,
Remand ,
Reversal
Freshub, Inc. v. Amazon.com, Inc., Appeal Nos. 2022-1391, -1425 (Fed. Cir. Feb. 26, 2024)
In the Court’s only precedential patent opinion this week, the Court affirmed a jury finding that use of Amazon’s “Alexa” products...more
Promptu Systems Corporation v. Comcast Corporation, Appeal No. 2022-1939 (Fed. Cir. Feb. 16, 2024)
Our Case of the Week focuses on a district court’s claim construction rulings in a patent case brought against Comcast...more
Univ. of South Florida Bd. of Trustees v. United States, Appeal No. 2022-2248 (Fed. Cir. Feb. 9, 2024)
In this week’s Case of the Week, the Federal Circuit examined the scope of a provision of the Bayh-Dole Act of 1980 (35...more
2/14/2024
/ Appeals ,
Bayh-Dole Act ,
Claim Construction ,
Federal Funding ,
Final Written Decisions ,
Inter Partes Review (IPR) Proceeding ,
Inventions ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Post-Grant Review ,
Prior Art
Roku, Inc. v. International Trade Commission, Appeal No. 2022-1386 (Fed. Cir. Jan. 19, 2024)
In an appeal from the International Trade Commission (the “Commission”), the Federal Circuit addressed a number of findings...more
Pacific Biosciences of California, Inc. v. Personal Genomics Taiwan, Inc., Appeal Nos. 2022-1410, -1554 (Fed. Cir. January 9, 2024)
In this week’s Case of the Week, the Federal Circuit affirmed two inter partes review...more
Dexcom, Inc. v. Abbott Diabetes Care, Inc., Appeal No. 2023-1795 (Fed. Cir. Jan. 3, 2024)
In our Case of the Week, the Court of Appeals for the Federal Circuit affirmed a district court’s denial of DexCom’s motion to...more
K-Fee System GmbH v. Nespresso USA, Inc., Appeal No. 2022-2042 (Fed. Cir. Dec. 26, 2023)
In an appeal from a district court judgment of noninfringement, the Federal Circuit reversed the underlying claim construction...more